Needham, MA, United States of America

David T Weaver

USPTO Granted Patents = 2 

 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: David T Weaver: Innovator in Therapeutic Compositions

Introduction

David T Weaver is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of abnormal cell growth, such as cancer. With a total of 2 patents to his name, Weaver's work is paving the way for advancements in immunotherapy.

Latest Patents

Weaver's latest patents focus on innovative methods that involve administering a FAK inhibitor alongside an immunotherapeutic agent, such as anti-PD-1 or anti-PD-L1. These inventions are particularly useful in treating cancer in mammals, especially humans. His research aims to enhance the effectiveness of cancer treatments by combining these therapeutic agents.

Career Highlights

David T Weaver is currently associated with Verastem, Inc., a company dedicated to developing innovative therapies for cancer treatment. His work at Verastem has allowed him to explore groundbreaking approaches to combat cancer, contributing to the company's mission of improving patient outcomes.

Collaborations

Weaver has collaborated with esteemed colleagues, including Jonathan A Pachter and Jennifer E Ring. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of effective cancer therapies.

Conclusion

David T Weaver's contributions to the field of therapeutic compositions highlight his commitment to advancing cancer treatment. His innovative patents and collaborations with other experts underscore the importance of teamwork in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…